Sustentación del trabajo de tesis titulada:

Value of the Information & Strength of the Argument

The value of the information is high, as it provides original data on genetic variants and risk factors in a Colombian population with HBOC, an understudied group. The argumentation is structured and follows a logical sequence from background to methodology, results, and discussion. The presenter clearly explains the research question, objectives, and methodology, including patient selection, genetic sequencing, and statistical analysis. The results are presented with appropriate context, and limitations are acknowledged, such as the lack of significant associations and the need for further validation. The argumentation is solid, though the presentation is limited by time constraints and the preliminary nature of the findings.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is evident in the use of established criteria (NCCN, ACMG) for patient selection and variant classification. The methodology is detailed, including DNA extraction, sequencing, and bioinformatics analysis. The study uses two different gene panels, which may introduce variability, but the manual curation of variants adds rigor. The sources cited are primarily the NCCN guidelines and ACMG standards, which are appropriate. The title accurately reflects the content, and the presentation adheres to the thesis defense format. No comments were provided, so no analysis of public trends is possible.

The title accurately reflects the content, which focuses on the association between modifiable risk factors, genetic factors, and tumor phenotype and clinical outcomes in Colombian patients with hereditary breast and ovarian cancer syndrome.

7/10

The presentation is a master's thesis defense, based on a funded research project with clear methodology, including genetic sequencing and statistical analysis. The study is original and uses established criteria (NCCN, ACMG). However, the presentation is limited in detail and the results are preliminary, with some limitations acknowledged.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction and welcome by the thesis director
• 02:00Presenter begins her defense, outlining the presentation structure
• 05:00Background on breast and ovarian cancer, and hereditary syndrome
• 10:00Explanation of genetic basis and limitations of previous studies in Latin America
• 15:00Description of tumor subtypes and risk factors
• 20:00Research question and objectives
• 25:00Methodology: study design, patient recruitment, and data collection
• 30:00Genetic analysis: DNA extraction, sequencing, and bioinformatics
• 35:00Statistical analysis methods
• 40:00Results: demographic and clinical characteristics, and genetic variants found
• 45:00Results: associations between risk factors, genetic variants, and tumor phenotypes
• 50:00Results: clinical outcomes and discussion of findings
• 55:00Conclusions and implications

• NCCN Clinical Practice Guidelines in Oncology: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic — Used for patient selection criteria for hereditary breast and ovarian cancer syndrome.
• ACMG Standards and Guidelines for the Interpretation of Sequence Variants — Used for classification of genetic variants.

• Prevalence of BRCA1 and BRCA2 mutations in Latin American populations — Supports the presence of BRCA mutations in Latin American populations, consistent with the study's findings.

• Association of modifiable risk factors with breast cancer subtypes